229 related articles for article (PubMed ID: 31885424)
1. Trends in treatment and overall survival among patients with proximal esophageal cancer.
de Vos-Geelen J; Geurts SM; van Putten M; Valkenburg-van Iersel LB; Grabsch HI; Haj Mohammad N; Hoebers FJ; Hoge CV; Jeene PM; de Jong EJ; van Laarhoven HW; Rozema T; Slingerland M; Tjan-Heijnen VC; Nieuwenhuijzen GA; Lemmens VE
World J Gastroenterol; 2019 Dec; 25(47):6835-6846. PubMed ID: 31885424
[TBL] [Abstract][Full Text] [Related]
2. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
[No Abstract] [Full Text] [Related]
3. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.
de Vos-Geelen J; Geurts SME; Nieuwenhuijzen GAP; Voncken FEM; Bogers JA; Braam PM; Muijs CT; de Jong MA; Kasperts N; Rozema T; Blom GJ; Bouwense SAW; Valkenburg-van Iersel LBJ; Jeene PM; Hoebers FJP; Tjan-Heijnen VCG
Eur J Surg Oncol; 2021 Aug; 47(8):2016-2022. PubMed ID: 33583629
[TBL] [Abstract][Full Text] [Related]
4. Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study.
Herrmann E; Mertineit N; De Bari B; Hoeng L; Caparotti F; Leiser D; Jumeau R; Cihoric N; Jensen AD; Aebersold DM; Ozsahin M
Radiat Oncol; 2017 Jun; 12(1):97. PubMed ID: 28615060
[TBL] [Abstract][Full Text] [Related]
5. Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre.
Wolf MC; Zehentmayr F; Schmidt M; Hölzel D; Belka C
Radiat Oncol; 2012 Apr; 7():60. PubMed ID: 22501022
[TBL] [Abstract][Full Text] [Related]
6. Increased resection rates and survival among patients aged 75 years and older with esophageal cancer: a Dutch nationwide population-based study.
Faiz Z; Lemmens VE; Siersema PD; Nieuwenhuijzen GA; Wouters MW; Rozema T; Coebergh JW; Wijnhoven BP
World J Surg; 2012 Dec; 36(12):2872-8. PubMed ID: 22965535
[TBL] [Abstract][Full Text] [Related]
7. Improvement in survival for patients with synchronous metastatic esophageal cancer in the south of the Netherlands from 1994 to 2013.
Bernards N; Haj Mohammad N; Creemers GJ; Rozema T; Roukema JA; Nieuwenhuijzen GA; van Laarhoven HW; van der Sangen M; Lemmens VE
Acta Oncol; 2016; 55(9-10):1161-1167. PubMed ID: 27174793
[TBL] [Abstract][Full Text] [Related]
8. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D
J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582
[TBL] [Abstract][Full Text] [Related]
9. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.
Koëter M; van Putten M; Verhoeven RHA; Lemmens VEPP; Nieuwenhuijzen GAP
Acta Oncol; 2018 Sep; 57(9):1192-1200. PubMed ID: 29528262
[TBL] [Abstract][Full Text] [Related]
10. Patterns of care and survival outcomes in the treatment of esophageal melanoma.
Weiner JP; Shao M; Schwartz D; Wong A; Schreiber D
Dis Esophagus; 2017 Feb; 30(2):1-6. PubMed ID: 27862623
[TBL] [Abstract][Full Text] [Related]
11. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
Wong AT; Shao M; Rineer J; Osborn V; Schwartz D; Schreiber D
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27860114
[TBL] [Abstract][Full Text] [Related]
12. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM
Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Management of Pathologic Node-Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer.
Polamraju P; Haque W; Verma V; Wiederhold L; Hatch S; Butler EB; Teh BS
Clin Colorectal Cancer; 2018 Sep; 17(3):e519-e530. PubMed ID: 29753642
[TBL] [Abstract][Full Text] [Related]
14. Addition of Definitive Radiotherapy to Chemotherapy in Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer.
Verma V; Allen PK; Simone CB; Gay HA; Lin SH
J Natl Compr Canc Netw; 2017 Nov; 15(11):1383-1391. PubMed ID: 29118230
[No Abstract] [Full Text] [Related]
15. Concurrent chemoradiotherapy for bladder cancer: Practice patterns and outcomes in the general population.
Ghate K; Brennan K; Karim S; Siemens DR; Mackillop WJ; Booth CM
Radiother Oncol; 2018 Apr; 127(1):136-142. PubMed ID: 29306498
[TBL] [Abstract][Full Text] [Related]
16. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer.
Wells SM; Boothe D; Ager BJ; Tao R; Gilcrease GW; Lloyd S
Clin Colorectal Cancer; 2020 Jun; 19(2):91-99.e1. PubMed ID: 32173281
[TBL] [Abstract][Full Text] [Related]
18. Management of pathologic node-positive disease following initial surgery for clinical T1-2 N0 esophageal cancer: patterns of care and outcomes from the national cancer data base.
Haque W; Verma V; Bernicker E; Butler EB; Teh BS
Acta Oncol; 2018 Jun; 57(6):782-789. PubMed ID: 29188742
[TBL] [Abstract][Full Text] [Related]
19. Treatment Modalities for Esophageal Adenocarcinoma in the United States: Trends and Survival Outcomes.
Di Corpo M; Schlottmann F; Strassle PD; Nurczyk K; Patti MG
J Laparoendosc Adv Surg Tech A; 2019 Aug; 29(8):989-994. PubMed ID: 31246532
[No Abstract] [Full Text] [Related]
20. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]